2型糖尿病肾病患者血清Chemerin与SOD、MDA的临床分析

doi:10.3969/j.issn.1000-8535.2019.02.002

广州医药 ›› 2019, Vol. 50 ›› Issue (2): 7-10.DOI: 10.3969/j.issn.1000-8535.2019.02.002

2型糖尿病肾病患者血清Chemerin与SOD、MDA的临床分析

卢建文, 银孟卓

广州市第一人民医院(广州 510180)

收稿日期:2018-12-13 出版日期:2019-03-20 发布日期:2021-12-17
基金资助:
广州市卫生和计划生育科技项目(20181A011009)

Analysis between plasma chemerin and SOD、MDA in patients with Type 2 diabetic nephropathy

LU Jianwen, YIN Mengzhuo

Guangzhou First People's Hospital,Guangzhou 510180,China

Received:2018-12-13 Online:2019-03-20 Published:2021-12-17

摘要/Abstract

摘要： 目的本研究旨在探讨2型糖尿病不同程度肾病与chemerin、SOD及MDA的相关性。方法选取2016年1月—2017年12月期间于广州市第一人民医院内分泌科门诊和住院的患者100例,根据尿白蛋白/肌酐比(ACR)分为正常尿蛋白组(NA组,n=33),微量白蛋白尿组(MA组,n=34)及大量蛋白尿组(CA组,n=33),另选取32例我院体检中心体检结果正常的正常健康人作为对照组(NC组,n=32),测定血糖、糖化血红蛋白、血肌酐、ACR、24小时尿蛋白定量、胆固醇、甘油三酯、SOD、MDA、chemerin等水平。结果 SOD的水平:NC组> NA组> MA组>CA组(P<0.05);MDA的水平:CA组>MA组>NA组>NC组(P<0.05);Chemerin水平:CA组>MA组>NA组>NC组(P<0.05)。相关性分析提示ACR与血清SOD呈负相关,与MDA、chemerin呈正相关。多元回归分析显示,病程、胆固醇、糖化血红蛋白、chemerin是影响ACR的主要因素。结论 Chemerin、MDA、SOD可能参与糖尿病肾病的发生发展,检测其水平可以在一定程度上反映2型糖尿病肾病患者的病情严重程度。

关键词: 糖尿病肾病, Chemerin, SOD, MDA

Abstract: Objective To explore the relationship between different type of Type 2 diabetes nephropathy and chemerin,SOD,MDA. Methods A total of 100 inpatients and outpatients were enrolled in this study between January 2016 and December 2017 in Guangzhou First People's Hospital. They were divided into normal urinary protein group (NA group, n=33), microalbuminuria group (MA group, n=34) and massive proteinuria group (CA group, n=33) based on ACR. Another 32 healthy people were collected as a control group in medical examination center (NC group, n=32). The levels of blood sugar, glycated hemoglobin, serum creatinine, ACR, 24-hour urinary protein, cholesterol, triglyceride, SOD, MDA and chemerin were measured. Results The level of SOD: NC group > NA group > MA group > CA group (P< 0.05). The level of MDA: CA group > MA group > NA group > NC group (P< 0.05). The level of chemerin: CA group > MA group > NA group > NC group (P< 0.05). Correlation analysis showed that ACR was negatively correlated with serum SOD and positively correlated with MDA and chemerin. Multivariate logistic regression demonstrated that course of disease, CHOL, HbA1c and chemerin were the main factors affecting ACR. Conclusion Chemerin, MDA and SOD may be involved in the occurrence and development of diabetic nephropathy. Chemerin, MDA and SOD may reflect the severity of type 2 diabetic nephropathy

Key words: Diabetic nephropathy, Chemerin, Superoxidedismutase (SOD), Malondiadehyde (MDA)

卢建文, 银孟卓. 2型糖尿病肾病患者血清Chemerin与SOD、MDA的临床分析[J]. 广州医药, 2019, 50(2): 7-10.

LU Jianwen, YIN Mengzhuo. Analysis between plasma chemerin and SOD、MDA in patients with Type 2 diabetic nephropathy[J]. Guangzhou Medical Journal, 2019, 50(2): 7-10.

[1]	许怡文, 李清初. 糖尿病肾病患者肾功能恶化进展的危险因素[J]. 广州医药, 2021, 52(5): 40-43.
[2]	银孟卓, 卢建文. 血浆chemerin水平与原发性高血压合并永久性心房纤颤的相关性研究[J]. 广州医药, 2018, 49(4): 13-16.
[3]	朱海霞, 李小晶, 王秀英, 梁惠慈. 儿童抗NMDA受体脑炎临床分析并文献复习[J]. 广州医药, 2017, 48(6): 36-39.
[4]	傅永锦, 刘艳波, 潘竞锵, 张小牧, 吕俊华. 川芎嗪对STZ诱导2型糖尿病大鼠肾病TLR4表达的影响[J]. 广州医药, 2017, 48(4): 12-16.
[5]	臧宁, 黄燕文, 岑美婷, 臧诗蕾. 呼气丙酮用于糖尿病肾病患者早期诊断的探讨[J]. 广州医药, 2017, 48(3): 26-28.
[6]	陈浩雄, 傅君舟, 何凤, 刘日光. 2型糖尿病肾病患者肾组织中STOML2的表达及作用[J]. 广州医药, 2016, 47(4): 42-44.
[7]	王安, 章秋, 方朝晖, 刘会前. 养血祛瘀方联合ARB/ACEI对糖尿病肾病患者尿蛋白治疗作用观察[J]. 广州医药, 2016, 47(2): 21-23.
[8]	蒋艳敏, 黄薇, 吴娟, 李敏清, 何平. 妊娠期糖尿病孕早中期脂肪细胞因子Chemerin、RBP4水平的研究[J]. 广州医药, 2015, 46(6): 30-32.

2型糖尿病肾病患者血清Chemerin与SOD、MDA的临床分析

Analysis between plasma chemerin and SOD、MDA in patients with Type 2 diabetic nephropathy

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 8

编辑推荐

Metrics

本文评价